Motegrity
Active Ingredient(s): Prucalopride SuccinateFDA Approved: * December 14, 2018
Pharm Company: * SHIRE DEV LLC
Category: Laxative
Prucalopride, brand names Resolor and Motegrity among others, is a drug acting as a selective, high affinity 5-HT4 receptor agonist[1] which targets the impaired motility associated with chronic constipation, thus normalizing bowel movements.[2][3][4][5][6][7] Prucalopride was approved for medical use in the European Union in 2009,[8] in Canada in 2011,[9&... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.